Market Research Logo
Publisher: BioSeeker Group AB
Category: Pharmaceuticals

Pharmaceuticals market research reports by BioSeeker Group AB

(222 reports matching your criteria)
  • Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool

    ... global interest and a growing list of stakeholders operating in this field. Users of this report get an un-biased, fact driven analysis of the position of each molecule and commercial player, always kept up to ... Read More

  • CAR/TCR Therapies in Oncology: Analytical Tool

    ... both Novartis and Kite Pharma (now Gilead Sciences) for being the first companies to bring these novel therapies to market with Kymriah (tisagenlecleucel-t) and Yescarta (axicabtagene ciloleucel) respectively. CAR/TCR Therapies in Oncology: Analytical Tool is ... Read More

  • Immuno-Oncology Drug Development: Analytical Tool

    ... current progress of immune-checkpoint inhibitors and CAR-T therapies to make the immune system fight cancer. Immuno-Oncology Drug Development: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who ... Read More

  • Oncolytic Virotherapies: Analytical Tool

    ... limited clinical efficacy as a single agent and therefore they are often being investigated in the combination with other forms of cancer therapy, including immune checkpoint inhibition. Oncolytic Virotherapies: Analytical Tool is the must have ... Read More

  • Cancer Vaccines: Analytical Tool

    ... turbocharged with the event of immune-checkpoint inhibitors. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot and ... Read More

  • Conjugated Antibodies in Oncology: Analytical Tool

    ... novel class of anticancer treatment agents that combines the selectivity of targeted treatment with the cytotoxic potency of chemotherapy drugs. Conjugated Antibodies in Oncology: Analytical Tool is the must have handbook for any business developer, ... Read More

  • Bispecific CD3 Molecules in Oncology: Analytical Tool

    ... expressed by the T-cell. Upon binding to both targets, these compounds redirect T-cell cytotoxicity toward the malignant cells and effectively eradicate them. Bispecific CD3 Molecules in Oncology: Analytical Tool is the must have handbook for ... Read More

  • Bispecific Molecules in Oncology: Analytical Tool

    ... tumor-targeted immunomodulators; and (II) dual immunomodulators. Bispecific Molecules in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot ... Read More

  • DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool

    ... DDR deficiencies to preferentially kill cancer cells, while minimizing the impact on normal cells, has potential for more selective, better tolerated therapies to improve survival in multiple cancers. DNA Damage Response (DDR) Drugs in Oncology: ... Read More

  • Epigenetic Therapies in Oncology: Analytical Tool

    ... under development and entering clinical trials. Epigenetic Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot ... Read More

  • Immune-checkpoint Drugs in Oncology: Analytical Tool

    ... changed the possibility to harness the power of the immune system in fighting cancer not only as a monotherapy but, maybe more importantly, also as a combination therapy. Immune-checkpoint Drugs in Oncology: Analytical Tool is ... Read More

  • Protein Kinase Inhibitors in Oncology: Analytical Tool

    ... genome encoding 538 protein kinases and many of these kinases being associated with human cancer initiation and progression, this field carries a lot of promise for more treatment successes in the future. Protein Kinase Inhibitors ... Read More

  • RNA Therapies in Oncology: Analytical Tool

    ... delivery technologies such nanoparticle carriers and conjugation strategies have allowed RNA therapeutics to enter clinical trials in the treatment of cancer. RNA Therapies in Oncology: Analytical Tool is the must have handbook for any business ... Read More

  • Commercial Interest at ESMO Annual Meeting 2018: Analytical Tool

    ... from the European Society of Medical Oncology (ESMO 2017) congress. Similar in scope to it's American cousin ASCO, this conference features more than 2000 abstracts detailing the latest ground-breaking science and in this too we ... Read More

  • Targeting the CD47-SIRPA Axis in Oncology: A Competitive Assessment of Technologies, Dual Targeting, Biomarkers, Combination Therapies & More

    ... seeking to target innate immune response. This report reveals intense global interest and a growing list of stakeholders operating in this field. Users of this report get an un-biased, fact driven analysis of the position ... Read More

  • Commercial Interests at ASCO 2017 - A 1stOncology Insights Report

    ... American Society of Clinical Oncology (ASCO) Annual Meeting 2017. Break through the mountain of close 5,000 abstracts presented at ASCO 2017 with a focused entry to reveal the identity and position of more than 470 ... Read More

  • Commercial Interests at ASGCT 2017 - A 1stOncology Insights Report

    ... American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2017. Break through the mountain of almost one thousand abstracts presented at ASGCT 2017 with a focused entry to reveal the identity and position of ... Read More

  • Commercial Interests at AACR 2017 - A 1stOncology Insights Report

    ... Meeting. This leading event in the oncology drug developers calender represents some of the very best in cancer science and this report allows the reader to review the meeting through the lens of 17 “hot” ... Read More

  • Finding and Evaluating Oncology Opportunities at BIO Asia 2017- A 1stOncology Insights Report

    ... must read for anyone with an interest in oncology at this exclusive partnering forum. This report features the oncology position and activities of 61 companies identified by the analyst team at 1stOncology™. This provides you ... Read More

  • Melanoma: Analytical Tool

    ... drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion Diagnostic ... Read More

  • Breast Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Leukemia: Analytical Tool

    ... drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion Diagnostic ... Read More

  • Prostate Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Cancer Immunotherapy: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Lung Cancer: Analytical Tool

    ... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

< prev 1 3 4 5 6 7 8 9

Research Assistance

Pharmaceuticals market research reports by BioSeeker Group AB

Join Alert Me Now!

Sign Up

Find out more on our blog